Infinity Pharmaceuticals (INFI) 15.73 $INFI
Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News
Zacks Research Staff - Zacks Investment Research - 2 hrs 52 mins ago
Shares of Infinity Pharma (INFI) are up more than 40 percent thanks to news of a partnership with AbbVie for a new cancer drug.
Infinity, AbbVie team on drug
at Investor's Business Daily - Wed Sep 03, 5:36PM CDT
Small biotech Infinity Pharmaceuticals (INFI) agreed to develop its blood cancer drug duvelisib, currently in trial stage, with big pharma AbbVie (ABBV). The deal includes an upfront payment of $275 mil to Infinity, and up to $530 mil in milestone...
Nasdaq stocks posting largest volume increases
AP - Wed Sep 03, 5:14PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Wed Sep 03, 5:14PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
After Yesterday's Rally of 44.05% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Sep 03, 3:46PM CDT
Infinity Pharmaceuticals (NASDAQ:INFI) traded in a range yesterday that spanned from a low of $14.56 to a high of $16.93. Yesterday, the shares gained 44.0%, which took the trading range above the 3-day high of $11.64 on volume of 17.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Delta and Office Depot are big market movers
AP - Wed Sep 03, 3:43PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
Infinity Pharma Joins AbbVie On Blood Cancer Drug
at Investor's Business Daily - Wed Sep 03, 12:20PM CDT
Development-stage biotech Infinity Pharmaceuticals (INFI) landed a key deal to develop its blood cancer drug duvelisib in partnership with big pharma AbbVie (ABBV), sending Infinity stock up 46% to a six-month high near 16 on the stock market today....
Why Infinity Pharmaceuticals Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Wed Sep 03, 12:12PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Infinity Pharmaceuticals , a...
Why Infinity Pharmaceuticals (INFI) Stock Is Soaring Today
at The Street - Wed Sep 03, 9:15AM CDT
Shares of Infinity Pharmaceuticals (INFI) soared in morning trading Wednesday after the company partnered with Abbvie (ABBV) to develop and market Infinity's experimental blood cancer drug IPI-145, or duvelisib.
Stock Futures Up And Climbing; Baidu Heads China Stock Rally
at Investor's Business Daily - Wed Sep 03, 8:08AM CDT
Stock futures showed strong gains ahead of Wednesday's open, as global markets rallied on word of a Ukraine/Russia cease-fire. Dow futures were 66.4 points above fair market value and leaning higher. Nasdaq 100 futures were up a strong 13. 3 points...
Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership
at The Street - Wed Sep 03, 5:57AM CDT
Infinity and Abbvie will jointly develop and market duvelisib.
Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology
PR Newswire Europe - Wed Sep 03, 5:45AM CDT
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones -
Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology
Business Wire - Wed Sep 03, 5:45AM CDT
--- Companies to Jointly Develop and Commercialize Duvelisib in U.S., with Equal Profit Share; Infinity to Receive Royalties on Sales Outside the U.S. -
Infinity Enters into Master Clinical Supply Agreement and Material Transfer Agreement with Roche
Business Wire - Wed Sep 03, 5:30AM CDT
--- Infinity to Supply Duvelisib for Roche Scientific Research -
Infinity to Participate in Two Conferences in September
Business Wire - Wed Aug 27, 7:00AM CDT
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following upcoming conferences:
3 Stocks Breaking Out With Unusual Volume
at The Street - Mon Aug 11, 6:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
3 Stocks Under $10 Making Big Moves
at The Street - Wed Aug 06, 6:47AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Infinity Reports Second Quarter 2014 Financial Results and Provides Company Update
Business Wire - Tue Aug 05, 7:03AM CDT
--- Topline Data Expected by Year-End from Phase 2 Studies of IPI-145 in Rheumatoid Arthritis and Asthma -
Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News
Zacks Research Staff - Zacks Investment Research - 2 hrs 52 mins ago
Shares of Infinity Pharma (INFI) are up more than 40 percent thanks to news of a partnership with AbbVie for a new cancer drug.
Infinity, AbbVie team on drug
at Investor's Business Daily - Wed Sep 03, 5:36PM CDT
Small biotech Infinity Pharmaceuticals (INFI) agreed to develop its blood cancer drug duvelisib, currently in trial stage, with big pharma AbbVie (ABBV). The deal includes an upfront payment of $275 mil to Infinity, and up to $530 mil in milestone...
Nasdaq stocks posting largest volume increases
AP - Wed Sep 03, 5:14PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - Wed Sep 03, 5:14PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
After Yesterday's Rally of 44.05% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Sep 03, 3:46PM CDT
Infinity Pharmaceuticals (NASDAQ:INFI) traded in a range yesterday that spanned from a low of $14.56 to a high of $16.93. Yesterday, the shares gained 44.0%, which took the trading range above the 3-day high of $11.64 on volume of 17.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Delta and Office Depot are big market movers
AP - Wed Sep 03, 3:43PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:
Infinity Pharma Joins AbbVie On Blood Cancer Drug
at Investor's Business Daily - Wed Sep 03, 12:20PM CDT
Development-stage biotech Infinity Pharmaceuticals (INFI) landed a key deal to develop its blood cancer drug duvelisib in partnership with big pharma AbbVie (ABBV), sending Infinity stock up 46% to a six-month high near 16 on the stock market today....
Why Infinity Pharmaceuticals Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Wed Sep 03, 12:12PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Infinity Pharmaceuticals , a...
Why Infinity Pharmaceuticals (INFI) Stock Is Soaring Today
at The Street - Wed Sep 03, 9:15AM CDT
Shares of Infinity Pharmaceuticals (INFI) soared in morning trading Wednesday after the company partnered with Abbvie (ABBV) to develop and market Infinity's experimental blood cancer drug IPI-145, or duvelisib.
Stock Futures Up And Climbing; Baidu Heads China Stock Rally
at Investor's Business Daily - Wed Sep 03, 8:08AM CDT
Stock futures showed strong gains ahead of Wednesday's open, as global markets rallied on word of a Ukraine/Russia cease-fire. Dow futures were 66.4 points above fair market value and leaning higher. Nasdaq 100 futures were up a strong 13. 3 points...
Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership
at The Street - Wed Sep 03, 5:57AM CDT
Infinity and Abbvie will jointly develop and market duvelisib.
Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology
PR Newswire Europe - Wed Sep 03, 5:45AM CDT
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones -
Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology
Business Wire - Wed Sep 03, 5:45AM CDT
--- Companies to Jointly Develop and Commercialize Duvelisib in U.S., with Equal Profit Share; Infinity to Receive Royalties on Sales Outside the U.S. -
Infinity Enters into Master Clinical Supply Agreement and Material Transfer Agreement with Roche
Business Wire - Wed Sep 03, 5:30AM CDT
--- Infinity to Supply Duvelisib for Roche Scientific Research -
Infinity to Participate in Two Conferences in September
Business Wire - Wed Aug 27, 7:00AM CDT
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following upcoming conferences:
3 Stocks Breaking Out With Unusual Volume
at The Street - Mon Aug 11, 6:00AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
3 Stocks Under $10 Making Big Moves
at The Street - Wed Aug 06, 6:47AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Infinity Reports Second Quarter 2014 Financial Results and Provides Company Update
Business Wire - Tue Aug 05, 7:03AM CDT
--- Topline Data Expected by Year-End from Phase 2 Studies of IPI-145 in Rheumatoid Arthritis and Asthma -
